CardioSignal

About:

CardioSignal offers a digital cardiac biomarker for self-monitoring, remote care, and point-of-care diagnostics.

Website: https://www.cardiosignal.com

Twitter/X: cardiosignal

Top Investors: Maki.vc, DigiTx Partners, Sandwater, MedTech Innovator

Description:

We develop groundbreaking solutions for the detection of heart diseases. CardioSignal is a mobile application and a certified medical device for the detection of atrial fibrillation. Originally an academic spinoff, the company’s patented technology is built on a decade of research and algorithm development. CardioSignal is a brand and a product by Precordior. www.cardiosignal.com

Total Funding Amount:

$15.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Turku, Western Finland, Finland

Founded Date:

2016-12-14

Contact Email:

info(AT)cardiosignal.com

Founders:

Henri Klimscheffskij, Juuso Blomster, Mikko Pänkäälä, Tero Koivisto, Tuomas Valtonen

Number of Employees:

11-50

Last Funding Date:

2024-05-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai